VIE/ZEAL (VIE/ZEAL)

Vienna Stock Exchange: VIE/ZEAL · EUR

€31.0

+0.34 (+1.1%)· Recorded snapshot

Market cap	2.1B
Revenue (ttm)	621.1M
Net income (ttm)	366.6M
EPS (ttm)	€5.16
P/E (trailing)	6.0x
Volume	5

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 621.1M
Net income (ttm): 366.6M
EPS (ttm): €5.16
P/E (trailing): 6.0x
Market cap: 2.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E6

P25 n/aP50 n/aP75 n/a

ROE16.3

P25 n/aP50 n/aP75 n/a

ROIC101.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ZEAL indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

DKK

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	AT
Earnings date	2026-11-12
Employees	578
Employees change	154
Employees growth	36.32%
Enterprise value	EUR 232.7M
Exchange	Vienna Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1997
Industry	Biotechnology
Is primary listing	No
ISIN number	DK0060257814
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Market cap	EUR 2.1B
Next earnings date	2026-11-12
Price	EUR 31.00
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/ZEAL
Website	https://www.zealandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	16.63%
EV/Earnings	0.57x
EV/EBIT	0.68x
EV/EBITDA	0.67x
EV/Sales	0.34x
FCF / EV yield	-114.68%
FCF yield	-11.5%
Graham number	65.40339
Graham upside	113.32%
P/B ratio	0.87x
P/E ratio	6.01x
P/S ratio	3.36x
Price / tangible book value	0.91x
Price/EBITDA ratio	6.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	49.68%
EBITDA margin	50.05%
Effective tax rate	3.49%
Gross margin	100%
Operating margin	49.68%
Pretax margin	61.16%
Profit margin	59.02%
Profit per employee	EUR 634,300
Profitable quarters	1
Profitable years	1
Revenue per employee	EUR 1.1M
ROA	7.81%
ROA (5Y)	-10.72%
ROCE	12.52%
ROE	16.31%
ROE (5Y)	-41.05%
ROIC	101.93%
ROIC (5Y)	-24.85%
SBC / revenue	2.88%
Tax / revenue	2.13%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-58.86%
EPS growth (Q)	-47.6%
EPS growth years	1
FCF growth (Q)	-95.38%
Gross profit growth	-49.05%
Gross profit growth (Q)	-50.58%
Gross profit growth 3Y	254.85%
Gross profit growth 5Y	121.44%
Net income growth	-58.97%
Net income growth (Q)	-48.28%
Net income growth years	1
OCF growth (Q)	-95.24%
Operating income growth	-67.89%
Operating income growth (Q)	-53.72%
Revenue growth	-49.02%
Revenue growth (Q)	-50.58%
Revenue growth (QoQ)	13,108.82%
Revenue growth 10Y	37.73%
Revenue growth 3Y	270.01%
Revenue growth 5Y	95.94%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -5.8M
Depreciation and amortization	EUR 2.3M
EBIT	EUR 308.6M
EBITDA	EUR 310.9M
EPS	EUR 5.16
Financing cash flow	EUR -68.2M
Free cash flow	EUR -240.3M
Free cash flow minus SBC	EUR -258.2M
Gross profit	EUR 621.2M
Income taxes	EUR 13.2M
Investing cash flow	EUR -150M
Net borrowing	EUR -3.8M
Net cash flow	EUR -428.9M
Net income	EUR 366.6M
Operating cash flow minus SBC	EUR -252.4M
Operating income	EUR 308.6M
Revenue	EUR 621.1M
Stock-based compensation	EUR 17.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.27
Book value per share	EUR 34.69
Debt / EBITDA	0.18
Debt / equity	0.02
Interest coverage	85.26
Long-term assets	EUR 142.5M
Long-term liabilities	EUR 56.8M
Net cash (debt)	EUR 1.9B
Net cash / market cap	89.93%
Net cash growth	-13.19%
Net debt / EBITDA	-6.04
Net debt / equity	-0.78
Piotroski F-Score	2
Property, plant and equipment	EUR 22.5M
Shareholders' equity	EUR 2.4B
Tangible book value	EUR 2.3B
Tangible book value per share	EUR 33.08
Total assets	EUR 2.6B
Total cash	EUR 1.9B
Total debt	EUR 55M
Total liabilities	EUR 235.7M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.25
Current assets	EUR 2.5B
Current liabilities	EUR 178.9M
Current ratio	13.98
Net working capital	EUR 391.2M
Quick ratio	13.76
Working capital	EUR 2.3B
Working capital turnover	0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.27%
Shareholder yield	0.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 39.23
1D price change	1.11%
1M price change	-13.46%
1M total return	-13.46%
1W price change	-0.23%
1W total return	-0.23%
20-day SMA	EUR 31.73
3M price change	-24.5%
3M total return	-24.5%
50-day SMA	EUR 36.19
52-week high	EUR 48.50
52-week high date	2026-05-07
52-week low	EUR 29.59
52-week low date	2026-10-19
6M price change	-25.21%
6M total return	-25.21%
All-time high	EUR 48.50
All-time high date	2026-05-07
All-time low	EUR 29.59
All-time low date	2026-10-19
Average true range (ATR)	EUR 0.85
Average volume	41.4
Change from 52-week high	-36.08%
Change from 52-week low	4.77%
Change from all-time high	-36.08%
Change from all-time low	4.77%
Change from open	1.44%
Day's gap	-0.33%
Dollar volume	EUR 155
High price	EUR 31.28
Low price	EUR 30.56
Monthly RSI	0
Open price	EUR 30.56
Position in 52-week range	61.11%
Previous close	EUR 30.66
Price vs 150-day SMA	-20.97%
Price vs 20-day SMA	-2.29%
Price vs 50-day SMA	-14.33%
Relative volume	0.12
RSI	37.68
Sharpe ratio	-0.13
Sortino ratio	-0.07
Volume	5
Weekly RSI	38.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.3M
Shares change (QoQ)	0.24%
Shares change (YoY)	-0.27%
Shares held by insiders	0.26%
Shares held by institutions	26.01%

Deeper analysis on VIE/ZEAL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ZEAL report

Is a complete VIE/ZEAL research report available?

No complete published report is available for vie/ZEAL (VIE/ZEAL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ZEAL (VIE/ZEAL)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ZEAL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ZEAL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ZEAL

Frequently asked questions